» Articles » PMID: 10567508

Parkinson's Disease: a Novel MRI Method for Determining Structural Changes in the Substantia Nigra

Overview
Date 1999 Nov 24
PMID 10567508
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To use MRI in a novel way to image and quantify the changes occurring in the substantia nigra in Parkinson's disease.

Methods: Six patients with idiopathic Parkinson's disease were compared with six age matched control subjects. The subjects were imaged using a combination of pulse sequences hypothesised to be sensitive to cell loss.

Results: The images showed patterns of change in patients with Parkinson's disease. Highly significant differences between the patients and control population were found (p<0.001).

Conclusions: This methodology suggests the possibility of detecting presymptomatic disease in those judged to be at risk, and also in confirming the diagnosis in patients with early disease. Furthermore, the technique seems to hold promise as a means for staging the disease, and possibly differentiating other forms of parkinsonism.

Citing Articles

Evaluation of Substantia Nigra morphology in Parkinson's Disease.

Durmaz Celik N, Yaman Kula A, Toprak U, Saylisoy S, Topal A, Ozkan S Medicine (Baltimore). 2024; 103(12):e37538.

PMID: 38518035 PMC: 10957011. DOI: 10.1097/MD.0000000000037538.


Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Heim B, Krismer F, De Marzi R, Seppi K J Neural Transm (Vienna). 2017; 124(8):915-964.

PMID: 28378231 PMC: 5514207. DOI: 10.1007/s00702-017-1717-8.


Spin-lattice distribution MRI maps nigral pathology in progressive supranuclear palsy (PSP) during life: a pilot study.

Hutchinson M, Raff U, Chana P, Huete I PLoS One. 2014; 9(1):e85194.

PMID: 24489655 PMC: 3904838. DOI: 10.1371/journal.pone.0085194.


Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease.

Aquino D, Contarino V, Albanese A, Minati L, Farina L, Grisoli M Neurol Sci. 2013; 35(5):753-8.

PMID: 24337946 DOI: 10.1007/s10072-013-1595-2.


Dystrophic serotonin axons in postmortem brains from young autism patients.

Azmitia E, Singh J, Hou X, Wegiel J Anat Rec (Hoboken). 2011; 294(10):1653-62.

PMID: 21901837 PMC: 4112519. DOI: 10.1002/ar.21243.